Teva to Sell Contraceptive Brand Paragard in $1.1 Billion Deal Teva to Sell Contraceptive Brand Paragard in $1.1 Billion Deal

Teva Pharmaceutical Industries on Monday agreed to sell its contraceptive brand Paragard to a unit of Cooper Cos for $1.1 billion, on a day the struggling Israeli drugmaker named industry veteran Kare Schultz as CEO.Reuters Health Information

Source: Medscape Today Headlines - September 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news